Actively Recruiting
GWAS to Identify Predictive Genetic Factors for the Success of Dietary Intervention in the Treatment of IBS Symptoms
Led by Attikon Hospital · Updated on 2025-04-06
100
Participants Needed
1
Research Sites
126 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a GWAS that aims to identify possible single nucleotide polymorphisms (SNPs) that are associated with the response in a combined dietary pattern low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols and Meditteranean diet (MED-LFD) in a small group of patients with Irritable Bowel Syndrome (IBS).
CONDITIONS
Official Title
GWAS to Identify Predictive Genetic Factors for the Success of Dietary Intervention in the Treatment of IBS Symptoms
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Fulfillment of the Rome IV criteria for IBS
- Provision of written informed consent
- Commitment of availability throughout the study period
- IBS-SSS > 175
You will not qualify if you...
- Any disease requiring special nutrition like renal failure, diabetes, celiac disease, cerebrovascular disease, or major surgery
- Pregnancy
- Breastfeeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Attikon General University Hospital of Athens
Athens, Greece, 12462
Actively Recruiting
Research Team
K
Konstantinos Triantafyllou, Proffesor
CONTACT
M
Maroulla Nikolaki, PhD (c)
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here